Loss of runt-related transcription factor 3 causes development and progression of hepatocellular carcinoma

Journal of Cellular Biochemistry

Volumn 112, Issue 3, 2011, Pages 745-749

  Shiraha, Hidenori ^a   Nishina, Shin Ichi ^a   Yamamoto, Kazuhide ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Apoptosis; Epithelial mesenchymal transition; Tumor suppressor gene

Indexed keywords

TRANSCRIPTION FACTOR RUNX3;

ANGIOGENESIS; APOPTOSIS; CANCER GROWTH; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL PROLIFERATION; DISEASE ASSOCIATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE MUTATION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CORE BINDING FACTOR ALPHA 3 SUBUNIT; DNA METHYLATION; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; GENES, NEOPLASM; HUMANS; LIVER NEOPLASMS; LOSS OF HETEROZYGOSITY; NEOVASCULARIZATION, PATHOLOGIC; PROMOTER REGIONS, GENETIC;

EID: 79951802134     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22973     Document Type: Review

References (50)

1. Araki K, Osaki M, Nagahama Y, Hiramatsu T, Nakamura H, Ohgi S, Ito H. 2005. Expression of RUNX3 protein in human lung adenocarcinoma: Implications for tumor progression and prognosis. Cancer Sci 96:227-231. (Pubitemid 40767060)
2. Armengol C, Boix L, Bachs O, Sole M, Fuster J, Sala M, Llovet JM, Rodes J, Bruix J. 2003. p27(Kip1) is an independent predictor of recurrence after surgical resection in patients with small hepatocellular carcinoma. J Hepatol 38:591-597. (Pubitemid 36560643)
3. Buendia MA. 2000. Genetics of hepatocellular carcinoma. Semin Cancer Biol 10:185-200.
4. Chang TL, Ito K, Ko TK, Liu Q, Salto-Tellez M, Yeoh KG, Fukamachi H, Ito Y. 2010. Claudin-1 has tumor suppressive activity and is a direct target of RUNX3 in gastric epithelial cells. Gastroenterology 138:255-265, e1-3.
5. Chen W, Gao N, Shen Y, Cen JN. 2010. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer. J Gastroenterol Hepatol 25:823-831.
6. Chi XZ, Yang JO, Lee KY, Ito K, Sakakura C, Li QL, Kim HR, Cha EJ, Lee YH, Kaneda A, Ushijima T, Kim WJ, Ito Y, Bae SC. 2005. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD. Mol Cell Biol 25:8097-8107. (Pubitemid 41263003)
7. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA. 2002. Mutations of the BRAF gene in human cancer. Nature 417:949-954. (Pubitemid 34716871)
8. de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, Fabre M, Chelly J, Beldjord C, Kahn A, Perret C. 1998. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 95:8847-8851. (Pubitemid 28350577)
9. De Souza AT, Hankins GR, Washington MK, Orton TC, Jirtle RL. 1995. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet 11:447-449.
10. El-Serag HB, Mason AC. 1999. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340:745-750. (Pubitemid 29114292)
11. El-Serag HB, Rudolph KL. 2007. Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology 132:2557-2576. (Pubitemid 46890874)
12. Fukamachi H, Ito K. 2004. Growth regulation of gastric epithelial cells by Runx3. Oncogene 23:4330-4335. (Pubitemid 38758598)
13. Gao J, Chen Y, Wu KC, Liu J, Zhao YQ, Pan YL, Du R, Zheng GR, Xiong YM, Xu HL, Fan DM. 2010. RUNX3 directly interacts with intracellular domain of Notch1 and suppresses Notch signaling in hepatocellular carcinoma cells. Exp Cell Res 316:149-157.
14. Guicciardi ME, Gores GJ. 2005. Apoptosis: A mechanism of acute and chronic liver injury. Gut 54:1024-1033. (Pubitemid 40873921)
15. Hu TH, Huang CC, Lin PR, Chang HW, Ger LP, Lin YW, Changchien CS, Lee CM, Tai MH. 2003. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma. Cancer 97:1929-1940.
16. Huang S, He J, Zhang X, Bian Y, Yang L, Xie G, Zhang K, Tang W, Stelter AA, Wang Q, Zhang H, Xie J. 2006. Activation of the hedgehog pathway in human hepatocellular carcinomas. Carcinogenesis 27:1334-1340. (Pubitemid 43985408)
17. Kim TY, Lee HJ, Hwang KS, Lee M, Kim JW, Bang YJ, Kang GH. 2004. Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma. Lab Invest 84:479-484. (Pubitemid 41656475)
18. Ku JL, Kang SB, Shin YK, Kang HC, Hong SH, Kim IJ, Shin JH, Han IO, Park JG. 2004. Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines. Oncogene 23:6736-6742. (Pubitemid 39280005)
19. Levanon D, Negreanu V, Bernstein Y, Bar-Am I, Avivi L, Groner Y. 1994. AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics 23:425-432. (Pubitemid 24308264)
20. Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, Kim HM, Kim WJ, Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe T, Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima T, Bae SC, Ito Y. 2002. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109:113-124. (Pubitemid 34327521)
21. Li J, Kleeff J, Guweidhi A, Esposito I, Berberat PO, Giese T, Buchler MW, Friess H. 2004. RUNX3 expression in primary and metastatic pancreatic cancer. J Clin Pathol 57:294-299. (Pubitemid 38338844)
22. Li X, Zhang Y, Qiao T, Wu K, Ding J, Liu J, Fan D. 2008. RUNX3 inhibits growth of HCC cells and HCC xenografts in mice in combination with adriamycin. Cancer Biol Ther 7:669-676.
23. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Haussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J. 2008. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378-390.
24. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA. 2008. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133:704-715. (Pubitemid 351636299)
25. Mathonnet M, Descottes B, Valleix D, Labrousse F, Denizot Y. 2006. VEGF in hepatocellular carcinoma and surrounding cirrhotic liver tissues. World J Gastroenterol 12:830-831. (Pubitemid 43380777)
26. Miyagawa K, Sakakura C, Nakashima S, Yoshikawa T, Kin S, Nakase Y, Ito K, Yamagishi H, Ida H, Yazumi S, Chiba T, Ito Y, Hagiwara A. 2006. Downregulation of RUNX1, RUNX3 and CBFbeta in hepatocellular carcinomas in an early stage of hepatocarcinogenesis. Anticancer Res 26:3633-3643. (Pubitemid 44701436)
27. Mori T, Nomoto S, Koshikawa K, Fujii T, Sakai M, Nishikawa Y, Inoue S, Takeda S, Kaneko T, Nakao A. 2005. Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma. Liver Int 25:380-388.
28. Moribe T, Iizuka N, Miura T, Kimura N, Tamatsukuri S, Ishitsuka H, Hamamoto Y, Sakamoto K, Tamesa T, Oka M. 2009. Methylation of multiple genes as molecular markers for diagnosis of a small, well-differentiated hepatocellular carcinoma. Int J Cancer 125:388-397.
29. Nakakura EK, Choti MA. 2000. Management of hepatocellular carcinoma. Oncology (Williston Park) 14:1085-1098, discussion 1098-1102.
30. Nishida N, Nagasaka T, Nishimura T, Ikai I, Boland CR, Goel A. 2008. Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma. Hepatology 47:908-918. (Pubitemid 351449682)
31. Noguera-Troise I, Daly C, Papadopoulos NJ, Coetzee S, Boland P, Gale NW, Lin HC, Yancopoulos GD, Thurston G. 2006. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 444:1032-1037. (Pubitemid 46018516)
32. Nomoto S, Kinoshita T, Kato K, Otani S, Kasuya H, Takeda S, Kanazumi N, Sugimoto H, Nakao A. 2007. Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma. Br J Cancer 97:1260-1265. (Pubitemid 350035807)
33. Ozturk M. 1999. Genetic aspects of hepatocellular carcinogenesis. Semin Liver Dis 19:235-242. (Pubitemid 29488766)
34. Park YN, Kim YB, Yang KM, Park C. 2000. Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis. Arch Pathol Lab Med 124:1061-1065. (Pubitemid 30602050)
35. Park WS, Cho YG, Kim CJ, Song JH, Lee YS, Kim SY, Nam SW, Lee SH, Yoo NJ, Lee JY. 2005. Hypermethylation of the RUNX3 gene in hepatocellular carcinoma. Exp Mol Med 37:276-281. (Pubitemid 41330037)
36. Peng Z, Wei D, Wang L, Tang H, Zhang J, Le X, Jia Z, Li Q, Xie K. 2006. RUNX3 inhibits the expression of vascular endothelial growth factor and reduces the angiogenesis, growth, and metastasis of human gastric cancer. Clin Cancer Res 12:6386-6394. (Pubitemid 44799709)
37. Ridgway J, Zhang G, Wu Y, Stawicki S, Liang WC, Chanthery Y, Kowalski J, Watts RJ, Callahan C, Kasman I, Singh M, Chien M, Tan C, Hongo JA, de Sauvage F, Plowman G, Yan M. 2006. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature 444:1083-1087. (Pubitemid 46018529)
38. Schaff Z, Hsia CC, Sarosi I, Tabor E. 1994. Overexpression of transforming growth factor-alpha in hepatocellular carcinoma and focal nodular hyperplasia from European patients. Hum Pathol 25:644-651. (Pubitemid 24230741)
39. Tada M, Omata M, Ohto M. 1990. Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reaction and direct sequencing. Cancer Res 50:1121-1124. (Pubitemid 20083997)
40. Teramoto T, Satonaka K, Kitazawa S, Fujimori T, Hayashi K, Maeda S. 1994. p53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis. Cancer Res 54:231-235.
41. Thiery JP. 2003. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15:740-746. (Pubitemid 37487967)
42. Thomas M. 2009. Molecular targeted therapy for hepatocellular carcinoma. J Gastroenterol 44(Suppl 19): 136-141.
43. Thorgeirsson SS, Teramoto T, Factor VM. 1998. Dysregulation of apoptosis in hepatocellular carcinoma. Semin Liver Dis 18:115-122. (Pubitemid 28224003)
44. Wada M, Yazumi S, Takaishi S, Hasegawa K, Sawada M, Tanaka H, Ida H, Sakakura C, Ito K, Ito Y, Chiba T. 2004. Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines. Oncogene 23(13):2401-2407. (Pubitemid 38496795)
45. Wang Y, Wu MC, Sham JS, Zhang W, Wu WQ, Guan XY. 2002. Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray. Cancer 95:2346-2352.
46. Wei D, Gong W, Oh SC, Li Q, Kim WD, Wang L, Le X, Yao J, Wu TT, Huang S, Xie K. 2005. Loss of RUNX3 expression significantly affects the clinical outcome of gastric cancer patients and its restoration causes drastic suppression of tumor growth and metastasis. Cancer Res 65:4809-4816. (Pubitemid 40740819)
47. Xiao WH, Liu WW. 2004. Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma. World J Gastroenterol 10:376-380.
48. Xue C, Plieth D, Venkov C, Xu C, Neilson EG. 2003. The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Res 63:3386-3394. (Pubitemid 36735899)
49. Yamada T, De Souza AT, Finkelstein S, Jirtle RL. 1997. Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis. Proc Natl Acad Sci USA 94:10351-10355. (Pubitemid 27407045)
50. Yamaguchi R, Yano H, Iemura A, Ogasawara S, Haramaki M, Kojiro M. 1998. Expression of vascular endothelial growth factor in human hepatocellular carcinoma. Hepatology 28:68-77. (Pubitemid 28299987)